Literature DB >> 12468353

Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.

Jayanthi S Lea1, Christine H Shin, Ellen E Sheets, Robert L Coleman, Paola A Gehrig, Linda R Duska, David S Miller, John O Schorge.   

Abstract

OBJECTIVE: To determine if performing an endocervical curettage (ECC) at the time of conization is a useful diagnostic tool for predicting residual cervical adenocarcinoma in situ (AIS) among women who might wish to preserve their fertility.
METHODS: All patients diagnosed with AIS from 1995 to 2000 at four institutions were identified. Data were retrospectively extracted from clinical records. Women included in the statistical analysis were (1) younger than 40 years, (2) had an ECC performed at the time of the initial cone biopsy, (3) had a clearly demarcated surgical margin pathologically, and (4) underwent a second surgical procedure.
RESULTS: Twenty-nine (24%) of 123 AIS patients met criteria for inclusion. The median age was 33 years (range, 17 to 39) and 13 (46%) were nulliparous. Initial surgery was a cold-knife conization (n = 17) or loop electrosurgical excision procedure (n = 12). Twelve (41%) ECCs and 15 (52%) cone margins were histologically positive. Sixteen patients underwent a repeat conization; 13 underwent hysterectomy. Thirteen (45%) patients had residual AIS at the time of their second surgical procedure. ECC had a superior positive predictive value (100% vs 47%; P < 0.01) and negative predictive value (94% vs 57%; P = 0.01) compared to cone margin in predicting residual AIS. None of the women undergoing fertility-sparing surgery developed recurrent AIS or adenocarcinoma.
CONCLUSION: ECC performed at the time of conization may be a useful tool for predicting residual AIS in women considering fertility preservation.

Entities:  

Mesh:

Year:  2002        PMID: 12468353     DOI: 10.1006/gyno.2002.6791

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Atypical Papanicolaou smear in pregnancy.

Authors:  Thomas P Connolly; A C Evans
Journal:  Clin Med Res       Date:  2005-02

Review 2.  Current state of fertility preservation for adolescent and young adult patients with gynecological cancer.

Authors:  Tatsuru Ohara; Shiho Kuji; Tomo Takenaga; Haruka Imai; Hiraku Endo; Ryo Kanamori; Jun Takeuchi; Yuko Nagasawa; Noriyuki Yokomichi; Haruhiro Kondo; Imari Deura; Akiko Tozawa; Nao Suzuki
Journal:  Int J Clin Oncol       Date:  2021-11-15       Impact factor: 3.402

Review 3.  Adenocarcinoma of the cervix.

Authors:  John O Schorge; Lynne M Knowles; Jayanthi S Lea
Journal:  Curr Treat Options Oncol       Date:  2004-04

Review 4.  Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.

Authors:  Deanna Teoh; Fernanda Musa; Ritu Salani; Warner Huh; Edward Jimenez
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

5.  Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.

Authors:  Huimin Bai; Jun Liu; Qiuxi Wang; Ying Feng; Tong Lou; Shuzhen Wang; Yue Wang; Mulan Jin; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.